GTF3C6
gene geneOn this page
Also known as bA397G5.3TFIIIC35
Summary
GTF3C6 (general transcription factor IIIC subunit 6, HGNC:20872) is a protein-coding gene on chromosome 6q21, encoding General transcription factor 3C polypeptide 6 (Q969F1). Involved in RNA polymerase III-mediated transcription. It is a selective cancer dependency (DepMap: 15.9% of cell lines).
RNA polymerases are unable to initiate RNA synthesis in the absence of additional proteins called general transcription factors (GTFs). GTFs assemble in a complex on the DNA promoter and recruit the RNA polymerase. GTF3C family proteins (e.g., GTF3C1, MIM 603246) are essential for RNA polymerase III to make a number of small nuclear and cytoplasmic RNAs, including 5S RNA (MIM 180420), tRNA, and adenovirus-associated (VA) RNA of both cellular and viral origin.
Source: NCBI Gene 112495 — RefSeq curated summary.
At a glance
- GWAS associations: 1
- Clinical variants (ClinVar): 42 total
- Cancer dependency (DepMap): dependent in 15.9% of screened cell lines
- MANE Select transcript:
NM_138408
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:20872 |
| Approved symbol | GTF3C6 |
| Name | general transcription factor IIIC subunit 6 |
| Location | 6q21 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | bA397G5.3, TFIIIC35 |
| Ensembl gene | ENSG00000155115 |
| Ensembl biotype | protein_coding |
| OMIM | 611784 |
| Entrez | 112495 |
Gene structure
Transcript identifiers
Ensembl transcripts: 21 — 20 protein_coding, 1 protein_coding_CDS_not_defined
ENST00000329970, ENST00000480191, ENST00000883260, ENST00000883261, ENST00000883262, ENST00000883263, ENST00000883264, ENST00000883265, ENST00000935759, ENST00000935760, ENST00000935761, ENST00000935762, ENST00000935763, ENST00000935764, ENST00000935765, ENST00000935766, ENST00000935767, ENST00000935768, ENST00000935769, ENST00000935770, ENST00000935771
RefSeq mRNA: 1 — MANE Select: NM_138408
NM_138408
CCDS: CCDS5087
Canonical transcript exons
ENST00000329970 — 6 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001448169 | 110958706 | 110958826 |
| ENSE00003464079 | 110959172 | 110959252 |
| ENSE00003491286 | 110960572 | 110960616 |
| ENSE00003614732 | 110962392 | 110962505 |
| ENSE00003635999 | 110967510 | 110967872 |
| ENSE00003660700 | 110960414 | 110960477 |
Expression profiles
Bgee: expression breadth ubiquitous, 134 present calls, max score 98.13.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 59.0295 / max 1373.9073, expressed in 1820 samples.
FANTOM5 promoters (5 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 69265 | 35.5581 | 1815 |
| 69266 | 21.5890 | 1805 |
| 69264 | 1.1843 | 773 |
| 69267 | 0.4180 | 149 |
| 69268 | 0.2800 | 93 |
Top tissues by expression
134 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| gastrocnemius | UBERON:0001388 | 98.13 | gold quality |
| muscle of leg | UBERON:0001383 | 97.93 | gold quality |
| heart left ventricle | UBERON:0002084 | 97.64 | gold quality |
| endometrium | UBERON:0001295 | 97.57 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 97.56 | gold quality |
| ganglionic eminence | UBERON:0004023 | 97.54 | gold quality |
| monocyte | CL:0000576 | 97.36 | gold quality |
| right testis | UBERON:0004534 | 97.35 | gold quality |
| substantia nigra | UBERON:0002038 | 97.27 | gold quality |
| amygdala | UBERON:0001876 | 97.19 | gold quality |
| leukocyte | CL:0000738 | 97.14 | gold quality |
| left testis | UBERON:0004533 | 97.14 | gold quality |
| putamen | UBERON:0001874 | 97.12 | gold quality |
| heart | UBERON:0000948 | 97.11 | gold quality |
| apex of heart | UBERON:0002098 | 97.11 | gold quality |
| caudate nucleus | UBERON:0001873 | 97.04 | gold quality |
| ventricular zone | UBERON:0003053 | 97.04 | gold quality |
| right adrenal gland | UBERON:0001233 | 96.97 | gold quality |
| rectum | UBERON:0001052 | 96.96 | gold quality |
| nucleus accumbens | UBERON:0001882 | 96.93 | gold quality |
| right atrium auricular region | UBERON:0006631 | 96.92 | gold quality |
| temporal lobe | UBERON:0001871 | 96.91 | gold quality |
| right adrenal gland cortex | UBERON:0035827 | 96.89 | gold quality |
| hypothalamus | UBERON:0001898 | 96.83 | gold quality |
| left adrenal gland | UBERON:0001234 | 96.70 | gold quality |
| prostate gland | UBERON:0002367 | 96.69 | gold quality |
| C1 segment of cervical spinal cord | UBERON:0006469 | 96.69 | gold quality |
| gall bladder | UBERON:0002110 | 96.65 | gold quality |
| testis | UBERON:0000473 | 96.56 | gold quality |
| mucosa of transverse colon | UBERON:0004991 | 96.53 | gold quality |
Single-cell (SCXA)
Detected in 2 experiment(s), a significant marker in 2.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-HCAD-9 | yes | 8.60 |
| E-ANND-3 | no | 0.00 |
Regulation
Is transcription factor: no
Functional genomics
DepMap (CRISPR cell-line fitness): dependent in 15.9% of screened cell lines.
Cross-species orthologs
4 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | gtf3c6 | ENSDARG00000043301 |
| mus_musculus | Gtf3c6 | ENSMUSG00000019837 |
| rattus_norvegicus | Gtf3c6 | ENSRNOG00000000586 |
| drosophila_melanogaster | CG42516 | FBGN0260390 |
Protein
Protein identifiers
General transcription factor 3C polypeptide 6 — Q969F1 (reviewed: Q969F1)
Alternative names: Transcription factor IIIC 35 kDa subunit, Transcription factor IIIC subunit 6
All UniProt accessions (1): Q969F1
UniProt curated annotations — full annotation on UniProt →
Function. Involved in RNA polymerase III-mediated transcription. Integral, tightly associated component of the DNA-binding TFIIIC2 subcomplex that directly binds tRNA and virus-associated RNA promoters.
Subunit / interactions. Part of the TFIIIC subcomplex TFIIIC2, consisting of six subunits, GTF3C1, GTF3C2, GTF3C3, GTF3C4, GTF3C5 and GTF3C6. Interacts with GTF3C4 and GTF3C5.
Subcellular location. Nucleus.
Similarity. Belongs to the TFIIIC subunit 6 family.
RefSeq proteins (1): NP_612417* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR019481 | TFIIIC_triple_barrel | Domain |
| IPR042771 | GTF3C6-like | Family |
Pfam: PF10419
UniProt features (7 total): region of interest 2, modified residue 2, initiator methionine 1, chain 1, compositionally biased region 1
Structure
Experimental structures (PDB)
1 structures.
| PDB | Method | Resolution (Å) |
|---|---|---|
| 8CLK | ELECTRON MICROSCOPY | 3.5 |
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q969F1-F1 | 66.32 | 0.28 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Post-translational modifications (2): 2, 9
Function
Pathways and Gene Ontology
Reactome pathways
6 pathways
| ID | Pathway |
|---|---|
| R-HSA-749476 | RNA Polymerase III Abortive And Retractive Initiation |
| R-HSA-76061 | RNA Polymerase III Transcription Initiation From Type 1 Promoter |
| R-HSA-76066 | RNA Polymerase III Transcription Initiation From Type 2 Promoter |
| R-HSA-74158 | RNA Polymerase III Transcription |
| R-HSA-74160 | Gene expression (Transcription) |
| R-HSA-76046 | RNA Polymerase III Transcription Initiation |
MSigDB gene sets: 105 (showing top):
GSE18804_BRAIN_VS_COLON_TUMORAL_MACROPHAGE_DN, GOBP_TRNA_METABOLIC_PROCESS, GRAESSMANN_APOPTOSIS_BY_SERUM_DEPRIVATION_UP, GRAESSMANN_RESPONSE_TO_MC_AND_SERUM_DEPRIVATION_UP, GOBP_TRANSCRIPTION_BY_RNA_POLYMERASE_III, GOBP_RRNA_TRANSCRIPTION, MONNIER_POSTRADIATION_TUMOR_ESCAPE_UP, MILI_PSEUDOPODIA_HAPTOTAXIS_UP, GOBP_DNA_TEMPLATED_TRANSCRIPTION_INITIATION, ACEVEDO_LIVER_CANCER_UP, GOCC_NUCLEAR_BODY, GOCC_TRANSCRIPTION_REGULATOR_COMPLEX, MARSON_BOUND_BY_FOXP3_STIMULATED, MARSON_BOUND_BY_FOXP3_UNSTIMULATED, GOBP_TRANSCRIPTION_INITIATION_AT_RNA_POLYMERASE_III_PROMOTER
GO Biological Process (3): transcription by RNA polymerase III (GO:0006383), 5S class rRNA transcription by RNA polymerase III (GO:0042791), tRNA transcription by RNA polymerase III (GO:0042797)
GO Molecular Function (3): RNA polymerase III general transcription initiation factor activity (GO:0000995), DNA binding (GO:0003677), protein binding (GO:0005515)
GO Cellular Component (4): transcription factor TFIIIC complex (GO:0000127), nucleoplasm (GO:0005654), nuclear body (GO:0016604), nucleus (GO:0005634)
Reactome top-level categories
Rollup of top-3 pathways:
| Category | Pathways |
|---|---|
| RNA Polymerase III Transcription | 2 |
| RNA Polymerase III Transcription Initiation | 2 |
| Gene expression (Transcription) | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| transcription by RNA polymerase III | 3 |
| DNA-templated transcription | 1 |
| rRNA transcription | 1 |
| tRNA transcription | 1 |
| general transcription initiation factor activity | 1 |
| nucleic acid binding | 1 |
| binding | 1 |
| RNA polymerase III transcription regulator complex | 1 |
| nuclear lumen | 1 |
| cellular anatomical structure | 1 |
| nucleoplasm | 1 |
| intracellular membraneless organelle | 1 |
| intracellular membrane-bounded organelle | 1 |
Protein interactions and networks
STRING
454 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| GTF3C6 | GTF3C5 | Q9Y5Q8 | 973 |
| GTF3C6 | GTF3C4 | Q9UKN8 | 947 |
| GTF3C6 | GTF3C1 | Q12789 | 854 |
| GTF3C6 | GTF3C3 | Q9Y5Q9 | 647 |
| GTF3C6 | GUCY2C | P25092 | 635 |
| GTF3C6 | TCF7 | P36402 | 586 |
| GTF3C6 | GOLGA6L1 | Q8N7Z2 | 573 |
| GTF3C6 | MT-CYB | P00156 | 568 |
| GTF3C6 | BASP1 | P80723 | 546 |
| GTF3C6 | GOLGA8O | A6NCC3 | 542 |
| GTF3C6 | GOLGA8Q | H3BV12 | 530 |
| GTF3C6 | GOLGA8N | F8WBI6 | 518 |
| GTF3C6 | SERBP1 | Q8NC51 | 506 |
| GTF3C6 | RPF2 | Q9H7B2 | 488 |
| GTF3C6 | GTF3C2 | Q8WUA4 | 448 |
IntAct
20 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| GTF3C1 | GTF3C2 | psi-mi:“MI:0914”(association) | 0.670 |
| GTF3C6 | SPATC1L | psi-mi:“MI:0915”(physical association) | 0.560 |
| ZNF460 | ZNF324 | psi-mi:“MI:0914”(association) | 0.530 |
| GTF3C6 | GTF3C5 | psi-mi:“MI:0915”(physical association) | 0.500 |
| GTF3C6 | GTF3C4 | psi-mi:“MI:0915”(physical association) | 0.500 |
| PCNA | GTF3C6 | psi-mi:“MI:0915”(physical association) | 0.370 |
| CD44 | TCAF2 | psi-mi:“MI:0914”(association) | 0.350 |
| BIN3 | NME2P1 | psi-mi:“MI:0914”(association) | 0.350 |
| GTF3C6 | GTF3C1 | psi-mi:“MI:0914”(association) | 0.350 |
| ZCCHC10 | C1orf226 | psi-mi:“MI:0914”(association) | 0.350 |
| ZNF460 | ZNF320 | psi-mi:“MI:0914”(association) | 0.350 |
| SPANXN2 | ZNF320 | psi-mi:“MI:0914”(association) | 0.350 |
| RPL15 | ZSWIM8 | psi-mi:“MI:0914”(association) | 0.350 |
| ZNF785 | CASK | psi-mi:“MI:0914”(association) | 0.350 |
| P/V | ESYT2 | psi-mi:“MI:0914”(association) | 0.350 |
| TTC8 | psi-mi:“MI:0914”(association) | 0.350 | |
| SPATC1L | GTF3C6 | psi-mi:“MI:0915”(physical association) | 0.000 |
BioGRID (38): GTF3C6 (Affinity Capture-RNA), GTF3C6 (Affinity Capture-MS), GTF3C6 (Affinity Capture-MS), GTF3C6 (Affinity Capture-MS), GTF3C6 (Affinity Capture-RNA), GTF3C6 (Affinity Capture-MS), GTF3C6 (Affinity Capture-MS), SPATC1L (Two-hybrid), GTF3C6 (Affinity Capture-MS), GTF3C6 (Affinity Capture-MS), GTF3C6 (Affinity Capture-RNA), GTF3C6 (Affinity Capture-MS), GTF3C6 (Affinity Capture-MS), GTF3C6 (Affinity Capture-MS), GTF3C6 (Affinity Capture-MS)
ESM2 similar proteins: A0P8Z5, A5A6N3, A6QPH9, D4A7U2, E2IUK4, E2RSQ2, G3HKI1, P28715, P35689, P97432, Q08DY8, Q13426, Q14159, Q14596, Q2HJ93, Q2KIY6, Q3U2E2, Q3UKU1, Q3ZK22, Q4R3D6, Q4R8B9, Q4R914, Q501R9, Q5F3F2, Q5RC94, Q5RD40, Q5RFG8, Q5RFL7, Q5TAB7, Q5VVJ2, Q5XI52, Q68FE8, Q69Z66, Q6N043, Q6P2K3, Q76CY8, Q7Z6J8, Q8IWR0, Q8N7W2, Q8NA31
Diamond homologs: Q969F1, Q9D8P7
SIGNOR signaling
1 interactions.
| A | Effect | B | Mechanism |
|---|---|---|---|
| GTF3C6 | “form complex” | TFIIIC | binding |
Disease & clinical
Clinical variants and AI predictions
ClinVar
42 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 25 |
| Likely benign | 1 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
640 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 6:110958818:G:GT | donor_gain | 1.0000 |
| 6:110958824:G:GT | donor_gain | 1.0000 |
| 6:110958827:GTA:G | donor_gain | 1.0000 |
| 6:110958897:G:GT | donor_gain | 1.0000 |
| 6:110960408:TTGTA:T | acceptor_loss | 1.0000 |
| 6:110960409:TGTA:T | acceptor_loss | 1.0000 |
| 6:110960410:GTAG:G | acceptor_loss | 1.0000 |
| 6:110960411:TA:T | acceptor_loss | 1.0000 |
| 6:110960412:A:AT | acceptor_loss | 1.0000 |
| 6:110960412:AG:A | acceptor_gain | 1.0000 |
| 6:110960413:GG:G | acceptor_gain | 1.0000 |
| 6:110960413:GGGC:G | acceptor_gain | 1.0000 |
| 6:110960475:AAGG:A | donor_loss | 1.0000 |
| 6:110960476:AGGTA:A | donor_loss | 1.0000 |
| 6:110960477:GG:G | donor_loss | 1.0000 |
| 6:110960478:GTAGG:G | donor_loss | 1.0000 |
| 6:110960479:T:A | donor_loss | 1.0000 |
| 6:110960570:A:AG | acceptor_gain | 1.0000 |
| 6:110960571:G:GA | acceptor_gain | 1.0000 |
| 6:110960571:GA:G | acceptor_gain | 1.0000 |
| 6:110960617:G:GC | donor_loss | 1.0000 |
| 6:110960618:TAAG:T | donor_loss | 1.0000 |
| 6:110962384:T:A | acceptor_gain | 1.0000 |
| 6:110962387:TCCA:T | acceptor_loss | 1.0000 |
| 6:110962388:CCA:C | acceptor_loss | 1.0000 |
| 6:110962390:A:AG | acceptor_gain | 1.0000 |
| 6:110962390:AGC:A | acceptor_loss | 1.0000 |
| 6:110962390:AGCT:A | acceptor_gain | 1.0000 |
| 6:110962391:G:GG | acceptor_gain | 1.0000 |
| 6:110962391:GC:G | acceptor_gain | 1.0000 |
AlphaMissense
1429 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 6:110960460:T:C | F62S | 0.998 |
| 6:110960466:G:A | G64E | 0.998 |
| 6:110960590:T:A | V74D | 0.998 |
| 6:110960432:C:T | P53S | 0.997 |
| 6:110960433:C:A | P53H | 0.997 |
| 6:110960459:T:C | F62L | 0.997 |
| 6:110960461:T:A | F62L | 0.997 |
| 6:110960461:T:G | F62L | 0.997 |
| 6:110959194:T:C | L27S | 0.996 |
| 6:110960439:T:C | L55P | 0.996 |
| 6:110960465:G:T | G64W | 0.996 |
| 6:110960580:G:A | G71R | 0.996 |
| 6:110960580:G:C | G71R | 0.996 |
| 6:110960581:G:A | G71E | 0.996 |
| 6:110960596:T:C | F76S | 0.996 |
| 6:110960433:C:G | P53R | 0.995 |
| 6:110960465:G:A | G64R | 0.995 |
| 6:110960465:G:C | G64R | 0.995 |
| 6:110962427:T:G | Y95D | 0.995 |
| 6:110962452:T:C | L103P | 0.995 |
| 6:110960460:T:G | F62C | 0.994 |
| 6:110960580:G:T | G71W | 0.994 |
| 6:110962452:T:A | L103H | 0.994 |
| 6:110960442:A:C | Q56P | 0.993 |
| 6:110960457:T:A | V61D | 0.993 |
| 6:110960462:G:C | A63P | 0.992 |
| 6:110960466:G:T | G64V | 0.992 |
| 6:110962428:A:C | Y95S | 0.992 |
| 6:110962458:T:A | M105K | 0.992 |
| 6:110962458:T:G | M105R | 0.992 |
dbSNP variants (sampled 300 via entrez): RS1000077608 (6:110961830 C>T), RS1000285598 (6:110967290 C>T), RS1000428351 (6:110962623 C>G), RS1000635946 (6:110967723 G>A,C,T), RS1000911119 (6:110957307 G>A), RS1001026355 (6:110963125 C>G,T), RS1001259737 (6:110956960 G>A,T), RS1001572963 (6:110962457 A>C,G), RS1001625484 (6:110962128 TC>T), RS1001683053 (6:110968336 C>T), RS1001768669 (6:110959610 G>C), RS1001791132 (6:110967851 A>ACT), RS1002137215 (6:110968197 T>A,C), RS1002158222 (6:110958313 A>C,T), RS1002575824 (6:110963539 G>C)
Disease associations
OMIM: gene MIM:611784 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
1 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST010002_332 | Refractive error | 3.000000e-10 |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
26 total (human), top 26 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| (+)-JQ1 compound | decreases expression | 6 |
| Valproic Acid | decreases expression | 3 |
| sodium arsenite | affects cotreatment, increases abundance, increases expression | 2 |
| Acetaminophen | decreases expression | 2 |
| dicrotophos | decreases expression | 1 |
| bisphenol A | affects cotreatment, decreases methylation | 1 |
| manganese chloride | affects cotreatment, increases abundance, increases expression | 1 |
| Sunitinib | decreases expression | 1 |
| Fulvestrant | affects cotreatment, decreases methylation | 1 |
| Air Pollutants | increases abundance, decreases expression | 1 |
| Arsenic | affects cotreatment, increases abundance, increases expression | 1 |
| Benzo(a)pyrene | affects methylation | 1 |
| Cadmium | increases expression | 1 |
| Camptothecin | increases expression | 1 |
| Diuron | decreases expression | 1 |
| Doxorubicin | decreases expression | 1 |
| Hydrogen Peroxide | affects expression | 1 |
| Lead | affects expression | 1 |
| Manganese | increases abundance, increases expression, affects cotreatment | 1 |
| Smoke | decreases expression | 1 |
| Thiram | decreases expression | 1 |
| Tobacco Smoke Pollution | increases expression | 1 |
| Urethane | decreases expression | 1 |
| Aflatoxin B1 | increases expression | 1 |
| Lactic Acid | decreases expression | 1 |
| Particulate Matter | increases abundance, decreases expression | 1 |
Cellosaurus cell lines
1 cell lines: 1 transformed cell line
First 10 cell lines (id-ordered, not curated):
| Cellosaurus | Name | Category | Sex |
|---|---|---|---|
| CVCL_B2YF | Abcam HEK293T GTF3C6 KO | Transformed cell line | Female |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.